Vyriad logo

Vyriad

Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.

Industries

Employees

51-200

Links


Org chart

Collapse

Board & advisors


Teams


Offices